Company / Interest Expense
Dexcom Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$14.3M
FY2025
5-year range
$14.3M / $18.8M
FY2021-FY2025
Trend
-4.0%
vs FY2024
Sector context
#35 of 44
Health Care
What the data says
Dexcom's interest expense of $14M is lower than 80% of companies in the Health Care sector (FY2025). Interest Expense has declined for 4 consecutive years, from $19M in FY2021 to $14M in FY2025.
Based on SEC 10-K filings.
$14M in FY2025 with a 5-year CAGR of -4.2%.
Improved from $16M to $14M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -6.9%
- 5-Year CAGR
- -4.2%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 44This company $14.3M Sector average $316.9M
▼
-95.5% below sector average
Key checks
Key Insights
- Dexcom's interest expense has declined for 4 consecutive years.
- 5-year CAGR of -4.2%, indicating a declining trend.
- In FY2025, interest expense decreased 4.0% year-over-year.
- Ranks #35 out of 44 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.3M | -4.0% |
| FY2024 | $14.9M | -9.1% |
| FY2023 | $16.4M | -7.3% |
| FY2022 | $17.7M | -5.9% |
| FY2021 | $18.8M | +6.2% |
| FY2020 | $17.7M | -70.6% |
| FY2019 | $60.3M | +165.6% |
| FY2018 | $22.7M | +5575.0% |
| FY2017 | $400.0K | -50.0% |
| FY2016 | $800.0K | -11.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026